Do I need to register legacy devices in EUDAMED?

Yes, most legacy devices must be registered in EUDAMED by 28 May 2026, when the mandatory registration period begins. Legacy devices are medical products that received CE marking under previous directives (MDD, AIMDD, or IVDD) but remain on the market. These devices must be registered in the UDI Device module if they continue to be placed on the EU market after the mandatory deadline.

What Exactly Qualifies As A Legacy Device Under EU MDR?

A legacy device is any medical device or IVD that received its CE marking under the previous European directives rather than under the current MDR or IVDR regulations. These devices obtained certification under one of three key directives:

• Medical Devices Directive (MDD 93/42/EEC) – Covering the majority of traditional medical devices from Class I through Class III
• Active Implantable Medical Devices Directive (AIMDD 90/385/EEC) – Specifically addressing implantable devices with active electrical components
• In Vitro Diagnostic Medical Devices Directive (IVDD 98/79/EC) – Governing laboratory diagnostic equipment and test systems

These legacy devices represent a significant portion of the current EU medical device market, as they were certified under well-established regulatory frameworks that governed device approval for decades. While the transition to MDR and IVDR brings enhanced safety requirements and more rigorous oversight, legacy devices continue to serve critical healthcare needs during the regulatory transition period.

Legacy devices can continue to be placed on the EU market during specific transition periods, even without full MDR or IVDR compliance. The key determining factor is whether the device maintains valid CE marking under its original directive. For most medical devices, this transition period extends until May 2024, although some categories have different timelines.

Additionally, the transition from MDD to MDR affects device classification in important ways. Some devices may be reclassified into higher-risk categories under MDR, which can impact their regulatory pathway and requirements. This reclassification does not automatically disqualify a device from legacy status, but it does influence the eventual transition requirements when the device seeks MDR certification.

Do All Legacy Devices Need To Be Registered In EUDAMED?

Not all legacy devices require EUDAMED registration, but most do if they remain commercially active on the EU market. The registration requirement applies specifically to legacy devices that continue to be placed on the market after 28 May 2026, when EUDAMED’s UDI Device module becomes mandatory.

Registration requirements depend on several key factors:

• Market activity status – Only devices that continue to be distributed or sold in EU member states require registration
• Risk classification coverage – All risk classes (I, IIa, IIb, and III) must be registered regardless of their original directive certification
• Commercial timeline – Registration must occur before devices can be placed on the market after the mandatory deadline
• Supply chain role – Manufacturers handle direct registration, while authorized representatives manage registrations for non-EU manufacturers
• Transition pathway – Devices successfully transitioning to full MDR/IVDR compliance register under new certification rather than legacy status

Understanding these registration criteria helps manufacturers develop targeted compliance strategies that focus resources on commercially active products while avoiding unnecessary administrative burden for discontinued devices. The distinction between “placed on the market” and “made available” also influences registration timing, as devices already in the distribution chain may have different compliance pathways than newly introduced products.

What Happens If You Don’t Register Your Legacy Devices In EUDAMED?

Failure to register legacy devices in EUDAMED by the mandatory deadline results in immediate market access restrictions. After 28 May 2026, unregistered legacy devices cannot be legally placed on the EU market, effectively blocking distribution and sales across all member states.

The consequences of non-compliance create cascading business and regulatory risks:

• Immediate market exclusion – Unregistered devices face automatic distribution bans across all EU member states
• Regulatory enforcement actions – Market surveillance investigations, mandatory product recalls, and administrative penalties from competent authorities
• Financial sanctions – Stop-sale orders and withdrawal requirements that can impose significant monetary penalties in USD
• Supply chain disruptions – Breach of existing contracts and inability to fulfill customer commitments
• Commercial relationship damage – Loss of distributor partnerships and healthcare provider contracts requiring compliance proof
• Market re-entry barriers – Complex remediation processes and potential reputation damage affecting future business opportunities

These enforcement measures represent more than administrative inconvenience—they can fundamentally disrupt established business models and market positions that took years to develop. The interconnected nature of EU medical device markets means that compliance failures in one member state often trigger investigations and restrictions across multiple jurisdictions, amplifying the business impact beyond the initial violation.

Risk mitigation strategies focus on proactive compliance planning. Companies should inventory their legacy device portfolios, prioritize registrations based on commercial importance, and establish clear timelines well ahead of the mandatory deadline. Additionally, maintaining accurate market status records helps ensure that discontinued products are not unnecessarily registered while active products receive proper attention.

How Do You Actually Register Legacy Devices In EUDAMED?

Legacy device registration in EUDAMED follows a two-step process: first completing Actor registration to obtain a Single Registration Number (SRN), then registering individual devices in the UDI Device module. Your Actor registration must be approved by competent authorities before you can proceed with device registrations.

The registration process involves several critical preparation and submission phases:

• Documentation gathering – Compile company registration details, authorized representative information, and comprehensive device technical data
• Code assignment – Obtain Basic UDI-DI codes, European Medical Device Nomenclature (EMDN) codes, and confirm device classifications
• Data structuring – Organize device specifications, intended use descriptions, risk classifications, and labeling details according to EUDAMED requirements
• Submission method selection – Choose between manual entry for smaller portfolios or XML file uploads for extensive device ranges
• Product mapping – Correctly align each Basic UDI-DI with product families and packaging configurations
• Timeline management – Complete Actor registration several months before May 2026 to avoid approval delays

These registration steps require careful coordination between technical, regulatory, and quality assurance teams to ensure data accuracy and completeness. The complexity increases significantly for manufacturers with diverse product portfolios, as each device family may require different coding schemes and regulatory pathways while maintaining consistency across the entire submission.

For practical implementation, manufacturers should test their submission methods early using available sandbox environments. This validation process identifies data structure issues, coding problems, and internal workflow gaps before the actual submission deadline. Organizations managing large portfolios often benefit from automated XML-based submissions rather than manual entry processes.

How MedEnvoy Global Helps With EUDAMED Legacy Device Registration

MedEnvoy Global provides comprehensive EUDAMED registration services to streamline your legacy device compliance while ensuring you meet the 28 May 2026 deadline. Our expert team manages the entire registration process from initial portfolio assessment through final submission, allowing you to maintain focus on your core business operations while achieving full regulatory compliance.

• Complete portfolio audit – We assess your legacy device inventory, identify registration requirements, and prioritize submissions based on commercial importance
• Technical data preparation – Our regulatory specialists compile all required documentation, assign appropriate codes, and structure data according to EUDAMED specifications
• Actor registration management – We handle your Single Registration Number (SRN) application and coordinate with competent authorities throughout the approval process
• Automated submission services – Using advanced XML-based systems, we efficiently register large device portfolios while maintaining accuracy and consistency
• Ongoing compliance monitoring – Post-registration support includes maintenance updates, regulatory change notifications, and continued EUDAMED management

Don’t risk losing EU market access for your legacy devices. Contact MedEnvoy Global today to secure your EUDAMED registration and ensure continued compliance with European medical device regulations.

Related Articles

• Do I need Swissdamed if I have EUDAMED?
• What is the difference between EUDAMED and Swissdamed?
• What Is NOM-241-SSA1 for Medical Devices?
• Can My Distributor Be My Registration Holder in Mexico?
• How do you Implement Effective Regulatory Risk Management Strategies?